LIG1 and cancer: As both CAPA and fluorescence imaging data supported that the LIG1(118–130)K126me2-CPP entered cells and accessed the nuclear compartment, we sought to determine whether this high-affinity LIG1 peptide was able to antagonize UHRF1 function in cancer cells.